Skip to main content
. 2017 Jan 19;17:15. doi: 10.1186/s12876-017-0572-2

Fig. 3.

Fig. 3

The proportion of patients maintaining virologic response (HBV DNA <60 IU/mL) in the study. Patients who discontinued the study prior to week 48 for any reason were considered failures in virologic response at the time of discontinuation